INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2015
|
Net Assets |
£263m |
|
Net Assets per share |
648p |
|
Share price |
582p |
|
Total value of unquoted investments |
£21m |
|
Total number of portfolio companies |
101 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
8.1 |
|
Gilead |
7.7 |
|
Amgen |
7.6 |
|
Regeneron |
6.8 |
|
Biogen |
5.7 |
|
Alexion |
4.3 |
|
Vertex |
3.7 |
|
Chimerix |
3.1 |
|
Biomarin |
3.0 |
|
Ophthotech |
2.6 |
|
|
----------- |
|
Total |
52.6 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
54 |
|
Turning Profitable 2015 |
8 |
|
Unprofitable |
38 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
84 |
|
Europe & UK |
16 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
93 |
|
Unquoted |
7 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
28 AUGUST 2015